期刊文献+

肝移植术后肝窦阻塞综合征的单中心诊疗经验 被引量:2

Diagnosis and treatment of hepatic sinusoidal obstruction syndrome after liver transplantation:a single-center experience
下载PDF
导出
摘要 目的总结肝移植术后肝窦阻塞综合征(HSOS)的发病情况和诊疗经验。方法回顾性分析4例肝移植术后HSOS患者的临床资料。收集肝移植术后HSOS的发病情况、临床表现、影像学及病理学特点,分析HSOS患者的治疗方式及转归情况。结果肝移植术后HSOS的发生率为0.8%(2/239),中位发病时间为肝移植术后4.5(1.7,9.0)个月。HSOS的临床表现主要包括腹胀、腹腔积液、肝肿大、胆红素升高,部分伴有肾功能不全。4例HSOS患者的腹部增强CT均呈“花斑样”不均匀强化;肝组织病理学表现主要为肝窦扩张伴淤血。4例患者均给予调整免疫抑制剂,将他克莫司(Tac)转换为环孢素,并加用华法林抗凝治疗,其中1例患者接受经颈静脉肝内门体静脉分流术(TIPS)治疗。3例患者经治疗后症状完全缓解,1例患者治疗无效死亡,1例患者在治疗好转后因肺部感染和消化道出血死亡。结论HSOS是肝移植术后少见但致命的并发症,及时的诊断和治疗可以避免移植物衰竭,改善患者预后。 Objective To summarize the incidence,diagnostic and therapeutic experience of hepatic sinusoidal obstruction syndrome(HSOS)after liver transplantation.Methods Clinical data of 4 patients with HSOS after liver transplantation were retrospectively analyzed.The incidence,clinical manifestations,imaging and pathological characteristics of HSOS after liver transplantation were collected,and the treatment methods and clinical outcomes of patients with HSOS were analyzed.Results The incidence of HSOS after liver transplantation was 0.8%(2/239),and the median time of onset was 4.5(1.7,9.0)months after liver transplantation.The clinical manifestations of HSOS mainly included abdominal distension,ascites,hepatomegaly,increased bilirubin,and renal insufficiency in partial cases.Enhanced abdominal CT scan of 4 patients with HSOS showed uneven spot-like enhancement and the liver histopathological examination mainly showed the signs of hepatic sinusoidal dilatation complicated with congestion.Four patients were administered with an adjusted regime of immunosuppressant by replacing tacrolimus(Tac)with ciclosporin and adding anticoagulant therapy with warfarin.One patient received transjugular intrahepatic portosystemic shunt(TIPS).After treatment,the symptoms of 3 patients were completely relieved,and 1 patient died.One of the 3 surviving patients died from pulmonary infection and gastrointestinal bleeding.Conclusions HSOS is a rare and fatal complication after liver transplantation.Timely diagnosis and treatment can avoid the incidence of graft failure and improve clinical prognosis of the patients.
作者 刘颖 孙丽莹 朱志军 魏林 曲伟 曾志贵 赵新颜 Liu Ying;Sun Liying;Zhu Zhijun;Wei Lin;Qu Wei;Zeng Zhigui;Zhao Xinyan(Liver Transplantation Center,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China)
出处 《器官移植》 CAS CSCD 北大核心 2021年第1期90-95,共6页 Organ Transplantation
基金 首都临床特色应用研究(Z181100001718220)。
关键词 肝窦阻塞综合征 肝移植 药物性肝损伤 抗凝治疗 腹腔积液 经颈静脉肝内门体静脉分流术 他克莫司 抗心磷脂抗体 Hepatic sinusoidal obstruction syndrome Liver transplantation Drug-induced liver injury Anticoagulant therapy Ascites Transjugular intrahepatic portosystemic shunt Tacrolimus Anticardiolipin antibody
  • 相关文献

参考文献3

二级参考文献19

  • 1Helmy A. Review article: updates in the pathogenesis andtherapy of hepatic sinusoidal obstruction syndrome. AlimentPharmacol Ther 2006; 23: 11-25 [PMID: 16393276 DOI: 10.1111/j.1365-2036.2006.02742.x].
  • 2Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, PagliucaA, Veys P, Potter MN. BCSH/BSBMT guideline: diagnosis andmanagement of veno-occlusive disease (sinusoidal obstructionsyndrome) following haematopoietic stem cell transplantation. BrJ Haematol 2013; 163: 444-457 [PMID: 24102514 DOI: 10.1111/bjh.12558].
  • 3Senzolo M, Germani G, Cholongitas E, Burra P, Burroughs AK.Veno occlusive disease: update on clinical management. WorldJ Gastroenterol 2007; 13: 3918-3924 [PMID: 17663504 DOI:10.3748/wjg.v13.i29.3918].
  • 4Tsirigotis PD, Resnick IB, Avni B, Grisariu S, Stepensky P, OrR, Shapira MY. Incidence and risk factors for moderate-to-severeveno-occlusive disease of the liver after allogeneic stem celltransplantation using a reduced intensity conditioning regimen.Bone Marrow Transplant 2014; 49: 1389-1392 [PMID: 25068424DOI: 10.1038/bmt.2014.168].
  • 5Azoulay D, Castaing D, Lemoine A, Samuel D, Majno P, ReynesM, Charpentier B, Bismuth H. Successful treatment of severeazathioprine-induced hepatic veno-occlusive disease in a kidneytransplantedpatient with transjugular intrahepatic portosystemicshunt. Clin Nephrol 1998; 50: 118-122 [PMID: 9725784].
  • 6Shah S, Budev M, Blazey H, Fairbanks K, Mehta A. Hepatic venoocclusivedisease due to tacrolimus in a single-lung transplantpatient. Eur Respir J 2006; 27: 1066-1068 [PMID: 16707401 DOI:10.1183/09031936.06.00048505].
  • 7Wang SE, Shyr YM, Lee RC. Hepatic veno-occlusive diseaserelated to tacrolimus after pancreas transplantation. J Chin MedAssoc 2013; 76: 358-360 [PMID: 23602212 DOI: 10.1016/j.jcma.2013.03.001].
  • 8Sebagh M, Azoulay D, Roche B, Hoti E, Karam V, Teicher E,Bonhomme-Faivre L, Saliba F, Duclos-Vallée JC, Samuel D.Significance of isolated hepatic veno-occlusive disease/sinusoidalobstruction syndrome after liver transplantation. Liver Transpl2011; 17: 798-808 [PMID: 21351239 DOI: 10.1002/lt.22282].
  • 9Mion F, Cloix P, Boillot O, Gille D, Bouvier R, Paliard P, Berger F.[Veno-occlusive disease after liver transplantation. Association ofacute cellular rejection and toxicity of azathioprine]. GastroenterolClin Biol 1993; 17: 863-867 [PMID: 8143956].
  • 10Sebagh M, Debette M, Samuel D, Emile JF, Falissard B, Cailliez V,Shouval D, Bismuth H, Reynès M. "Silent" presentation of venoocclusivedisease after liver transplantation as part of the process ofcellular rejection with endothelial predilection. Hepatology 1999;30: 1144-1150 [PMID: 10534334 DOI: 10.1002/hep.510300514].

共引文献41

同被引文献21

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部